Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Xiaoming Qiu
Sichuan University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
60
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Perioperative Treatment in Egfr-Mutant Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Future Perspectives
Number of pages: 25
Posted: 21 Jun 2024
Xiaobei Guo
,
Xiaoyan Liu
,
Chao Guo
,
Qian Miao
,
Xinghua Cheng
,
Xuan Hong
,
Hong-Ru Li
, Xiaoming Qiu,
Yi Xiang
,
Di Zheng
,
Jian Zhou
,
Li-Yan Jiang
,
Yan Xu
and
Mengzhao Wang
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Fujian Medical University - Department of Thoracic Oncology, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Harbin Medical University - Department of Medical Oncology, Fujian Medical University - Fujian Provincial Hospital, Sichuan University, Sichuan University, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Government of the People's Republic of China - Beijing Hospital and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Respiratory and Critical Care Medicine
Downloads
60
(961,006)
View PDF
Download
Abstract:
EGFR-mutant, early-stage NSCLC, (neo)adjuvant targeted therapy, Neoadjuvant immunotherapy, ctDNA
Feedback